A 26-week pilot study of women with stress urinary incontinence found INNOVO® significantly improved their symptoms
In one controlled, randomized, double-blind clinical study, researchers found INNOVO users attained an 81.3% improvement in their pelvic floor strength over 12 weeks — an increase of nearly 48%.3
Another study of users who participated in the full INNOVO treatment found 81.3% of patients showed moderate to good pelvic floor muscle contractions, compared to the 47% baseline.3
Ultrasounds performed on INNOVO user over eight weeks of treatment showed:
A randomized, controlled trial conducted across 12 centers in the U.S. found patients who used INNOVO for the three-month treatment had a significant improvement in their quality of life.2
A randomized, controlled trial conducted across 12 centers in the U.S. found 87.2% of INNOVO users reported being dry or nearly dry after 12 weeks – a nearly 33% improvement.